DCPH

Deciphera Pharmaceuticals, Inc. Common Stock

Delisted

DCPH was delisted on the 10th of June, 2024.

127 hedge funds and large institutions have $545M invested in Deciphera Pharmaceuticals, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 46 increasing their positions, 38 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
127
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$6.18M
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$37.6M
2 +$15.8M
3 +$12.5M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$10.5M
5
RG
Redmile Group
California
+$10.1M

Top Sellers

1 -$23.8M
2 -$13.4M
3 -$10.2M
4
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$4.23M
5
UBS Group
UBS Group
Switzerland
-$4.06M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$82.2M
2
$72.7M
3
$57.8M
4
$51.7M
5
$48.2M
6
$18.8M
7
$15.9M
8
$15.8M
9
$15.8M
10
$12.3M
11
$11.9M
12
$10.9M
13
$10.5M
14
$9.27M
15
$9.09M
16
$8.65M
17
$8.32M
18
$5.7M
19
$5.18M
20
$4.73M
21
$4.71M
22
$4.68M
23
$4.32M
24
$2.37M
25
$2.35M